Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

Recruiting now · Phase 4

Conditions studied: Robotic Lung Surgery

In brief

This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.

Key facts

Study ID

NCT03906617

Run by

The Cooper Health System

People needed

34

Starts

2019-04-10

Expected to finish

2022-06-10

Last updated by the study team

2021-11-12

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• undergoing robotic wedge resection or lobectomy for lung mass(es)

You may not qualify if…

• emergency case
• history of opiate abuse
• chronic pain syndrome
• intravenous drug use
• chronic use of oral steroids
• pregnancy
• imprisonment
• body weight lower than 70 kg
• liver failure
• uninsured patients
• non-verbal patients or patients who are unable to rate their pain on a visual analogue pain scale
• history of allergic reaction to any of the drugs used in the study: bupivacaine, liposomal bupivacaine, dexamethasone

Where it is running

• Cooper University Hospital — Camden, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.